Share Name Share Symbol Market Type Share ISIN Share Description
The Biotech Growth Trust LSE:BIOG London Ordinary Share GB0000385517 ORD 25P
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  +3.00p +0.36% 834.00p 828.00p 834.00p 836.00p 816.00p 826.00p 87,774 16:35:24
Industry Sector Turnover (m) Profit (m) EPS - Basic PE Ratio Market Cap (m)
Equity Investment Instruments 1.6 0.8 1.1 758.2 464.92

Biotech Growth Trust Share Discussion Threads

Showing 301 to 323 of 325 messages
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
DateSubjectAuthorDiscuss
04/4/2018
10:33
Or maybe the funds management are too busy sipping champagne on our money to notice the money we trusted them with is evaporating.
andyj
04/4/2018
00:56
Share price nearly 10% below NAV now, should see some buy backs.
andyj
28/3/2018
17:06
I will settle for getting my money back
andyj
28/3/2018
08:06
Will be £10+ before years out..
losses
26/3/2018
14:45
9% drop in the NAV last week.
andyj
28/2/2018
14:08
By the way, there is an excellent and insightful free research paper on BIOG at Edison Investment Research dated Feb 22. Sorry I cannot post the link.
andyj
28/2/2018
13:48
Thanks all, probably sound advice, just having a clear out of underperforming investments in my portfolio and noticed BIOG has consistently been a losing investment for me.
andyj
28/2/2018
13:21
For me I'm in as it broadens my spread and exposure. But I also get into something that in the long term should imho do well. I believe we'll make the same stride in bio than we have made in technologies e.g google maps, smart phones etc we have had. Agree though don't like spikes but in the long term not an issue. I also don't care about the discount as that will come back with performance.
the oak tree
28/2/2018
11:59
I agree. good safe long term hold.
shaker44
28/2/2018
11:21
This one is not for trading Andy.. but and forget... couple years down the road it will double...
losses
28/2/2018
11:09
I have had enough of this fund. The discount is widening, the spread is often ridiculously wide and the way it has spiked up in recent years concerns me. I will try to get my money back.
andyj
02/1/2018
14:14
Was expecting this to follow net asset value which is way above 800..
losses
06/12/2017
22:05
I was wondering why this started dropping... hopefully get back on the up soon.
losses
21/11/2017
06:13
I agree, huge potential in biotech and rather those with expertise choose the companies to invest in than me. 2% discount to NAV, I I am in.
andyj
19/11/2017
22:20
Bought in here on Friday so keen on others views. Its had a good run though and little if any discount. Its part of a balanced portfolio but feel its a merited position due to this sector perhaps going through what technology has done this last 20 years. Bio science will have its iPhone / google maps moment as some point in the next 10-20 years I reckon. IMHO
the oak tree
22/6/2017
05:28
https://seekingalpha.com/news/3274927-biotechs-blaze-trump-draft-order-drug-prices-ease-regulations
hutch_pod
01/3/2017
11:05
Yeah. Good luck. Personally I believe markets to be more event driven.e.g. geo-political, and trumps income/spending mismatch.And attack on healthcare. So I am more likely a seller at this level whatever charts may indicate...
shaker44
01/3/2017
10:18
This stuff works for me and I'm not leveraged. I use TA on all assets to establish entries targets and exits. We've been stuck at this 740-760 resistance for some months(which coincidentally is the 61.8% retracement of the July 2015 - Jun 2016 correction therefore its likely others also apply TA to this fund). If we can clear sellers from this level and break above this resistance (which we're currently trying to do) it should become a good level of support in the future and an area I will use to add to my current position with a medium term target of 970-1000p. Each to their own ;-)
powersno1
28/2/2017
12:24
If you really believe that stuff you will go leveraged long I guess. But personally I can not see how a chart can predict a fund like this!
shaker44
28/2/2017
10:39
If we can breakout and establish ourselves above 765p we have a technical inverse head and shoulder medium term target of circa 980-1000p
powersno1
18/1/2017
09:10
Now it's 10% discount to nav. Biog should now be buying their own shares back, let's see.....
earthmanian
04/1/2017
15:40
Still a bit of a discount actually esp with the continuing US biotech rallies, for the moment anyway.
hutch_pod
04/1/2017
10:27
IBT has narrowed as well to 10%.
philo124
Chat Pages: 13  12  11  10  9  8  7  6  5  4  3  2  Older
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20180722 18:11:34